The short interest in biotech and emerging pharmaceutical companies was mixed again in the first two weeks of January. The number of shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA ), Dendreon (NASDAQ: DNDN ), Gilead Sciences (NASDAQ: GILD ), Onyx Pharmaceuticals (NASDAQ: ONXX )